Pages that link to "Q35955354"
Jump to navigation
Jump to search
The following pages link to Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer (Q35955354):
Displaying 9 items.
- Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect (Q26775578) (← links)
- Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy. (Q36396832) (← links)
- Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma. (Q38633640) (← links)
- Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM. (Q38726535) (← links)
- CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy (Q38850275) (← links)
- Targeted alpha therapy using a novel CD70 targeted thorium-227 conjugate in in vitro and in vivo models of renal cell carcinoma (Q41346916) (← links)
- CD70 as a target for chimeric antigen receptor T cells in head and neck squamous cell carcinoma. (Q52678805) (← links)
- Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation (Q89097027) (← links)
- Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status (Q96431598) (← links)